Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06740162 · ClinicalTrials.gov registry record · NA
Physical Activity and Community EmPOWERment Project
A NA study of Autism Spectrum Disorder and Down Syndrome, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 376
- Enrollment target
- 2
- Study locations
NCT06740162 is a NA study of Autism Spectrum Disorder and Down Syndrome that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 376 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (181% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06740162, a NA study of Autism Spectrum Disorder and Down Syndrome, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
- 2
- Study locations
Study Summary
Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD). Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recruited through the University of North Carolina at Chapel Hill and the University of Arkansas. Participants also include 16 exercise professionals. Procedures (methods): Each cohort will include 20 triads who are randomly assigned to the PACE program or the waitlist control group.
Conditions Studied
Interventions
- BEHAVIORAL PACE Program
Study Locations (2)
Arkansas
- University of Arkansas - Fayetteville
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06740162
The ClinicalTrials.gov registry entry for NCT06740162 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (181% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which PACE Program is the first listed.
NCT06740162 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arkansas, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06740162 about?
NCT06740162 is a clinical study titled "Physical Activity and Community EmPOWERment Project". Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD). Participants: Participants include 120 adults with...
What is the current status of trial NCT06740162?
This trial is currently recruiting. It is a NA study. The enrollment target is 376 participants. The study started on 2025-01-10. Estimated completion is 2028-06.
What conditions does trial NCT06740162 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Down Syndrome, Neurodevelopmental Disorders, Intellectual Disability, Fragile X Syndrome.
What interventions are being tested in trial NCT06740162?
The interventions under investigation include: PACE Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06740162?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06740162 being conducted?
This trial has 2 study locations across Arkansas, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
-
STEPS Implementation Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.